We are pleased to invite you to attend and participate in the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) 2023 International Conference on Emerging Infectious Diseases in the Pacific Rim and associated Panel/Board meetings from March 7-10, 2023, at Acacia Hotel, Alabang. This conference is co-organized by the Department of Science and Technology (DOST), Japan Agency for Medical Research and Development (AMED), and the U.S. National Institutes of Health (NIH).

The focus of the 2023 EID conference is on bacterial and parasitic diseases/infections and associated cancers of importance in the Asia-Pacific region and of global health concern. The conference objectives are to share current research findings and foster existing and potential international research collaborations that engage scientists and institutions in the Asia-Pacific region and the United States.

Target on-site participants are 300 and a maximum of 1000 participants for the online platform. No registration fee will be charged but registration is required. Participants who will be attending the on-site event shall cover their own accommodation and travel expenses. Please signify your interest and confirm your participation by registering directly through this link: https://tinyurl.com/2023EID.

You may access the working program here: https://tinyurl.com/4vkz6yvr

The Regional Health Research and Development Consortium XI (RHRDC XI) is now accepting Health Research and Development proposals for CY 2023 funding support. This is made possible through funding support from the Philippine Council for Health Research and Development (PCHRD). The proposal must be based on the priority areas indicated in the 2017-2022 Region XI Regional Unified Health Research Agenda (RUHRA). The 2017-2022 RUHRA may be downloaded thru this link: http://region11.healthresearch.ph/index.php/downloads-2/category/16-ruhra.

Frequently Asked Questions:

Who can apply?

Researchers and faculty of RHRDC XI member institutions who have permanent or regular status. We highly encouraged young and budding researchers to grab this opportunity.

I am interested in conducting research, but I am not yet a regular or permanent personnel in our institution?

            You may opt to partner with a colleague who is a permanent or regular employee. He or she will be the primary investigator of the study. This arrangement must be made internally within your institution.

How much is the funding support?

Funding support is up to Php 1,000,000. However, this will depend on your proposal. The evaluators will check if the budget is reasonable. 

What should be the duration of my proposal?

Your proposal must be feasible in 6 months – 1 year.

What to submit?

1. capsule proposal. You may download the format HERE

2. Endorsement from the Head of Institution addressed to Dr. Warlito C. Vicente, Chair, RHRDC XI (free format)

3. Curriculum Vitae of the proponent/s (free format)

When is the submission?

            Submission of the capsule proposal, endorsement letter from the head of institution and curriculum vitae of the proponent/s is on February 17, 2023. RHRDC XI will not be catering late and/or incomplete submissions. 

You may send a soft copy of the requirements through email at This email address is being protected from spambots. You need JavaScript enabled to view it.,  (Kindly put in the subject: 2023 RRF). We highly discourage hard copy submissions.

For further queries, you may email us at This email address is being protected from spambots. You need JavaScript enabled to view it., message through our facebook account: https://www.facebook.com/rhrdcdavao/ or telephone at (082) 221-9721.

I already submitted last 2022 will it still be considered?

Earlier proposals submitted and were categorized as priority are still considered for funding and is in pipeline for review. You may email This email address is being protected from spambots. You need JavaScript enabled to view it. for the current status of your proposal.


Featured Links












July 2024
30 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31 1 2 3